Fachrepositorium Lebenswissenschaften

8 Treffer

Suche

Publisso-Menue

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC

2021 . Weber, Daniel | Decker, Miriam | Schuster, Michael | Folz, Sara | Stürmer, Carsten Johannes | Lutz, Manfred

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

2021 . Unterrainer, Marcus | Taugner, Julian | Käsmann, Lukas | Tufman, Amanda | Reinmuth, Niels | Li, Minglun | Mittlmeier, Lena M. | Bartenstein, Peter | Kunz, Wolfgang G. | Ricke, Jens | Belka, Claus | Eze, Chukwuka | Manapov, Farkhad

AI-Based Drug Discovery of TKIs Targeting L858R/T790M/C797S-Mutant EGFR in Non-small Cell Lung Cancer

2021 . Choi, Geunho | Kim, Daegeun | Oh, Junehwan

Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps

2021 . Mueller, Sebastian Johannes | Khadhraoui, Eya | Neef, Nicole E. | Riedel, Christian Heiner | Ernst, Marielle

Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases

2021 . Agaimy, Abbas | Daum, Ondrej | Michal, Michal | Schmidt, Mona W. | Stoehr, Robert | Hartmann, Arndt | Lauwers, Gregory Y.

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

2020 . Bozorgmehr, Farastuk | Chung, Inn | Christopoulos, Petros | Krisam, Johannes | Schneider, Marc A. | Brückner, Lena | Mueller, Daniel Wilhelm | Thomas, Michael | Rieken, Stefan

Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer

2020 . ten Thoren, C. | Balg, C. | Gibbert, J. | Mostardt, S. | Ripoll, M. | Schierbaum, D. | Schiller, S. | Schwalm, A.